Search results
Results from the WOW.Com Content Network
Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). [ 4 ] [ 5 ] The medication improves sexual desire, increases the number of satisfying sexual events, and decreases the distress associated with low sexual desire. [ 6 ]
That includes flibanserin, the trade name for which is Addyi. ... Addyi is a pill that should be taken orally every night. Clinical studies show that after eight to 12 weeks it does boost the ...
Currently, there are two such FDA-approved medications — Addyi (flibanserin) and Vyleesi (bremelanotide) — and some physicians will also prescribe testosterone, as well as the antianxiety drug ...
Flibanserin [1] and Bremelanotide [3] were developed for raising sexual desire in women, whereas similar conditions in men are treated using medications for sexual dysfunction. [4] On the other hand, down-regulation on libido comes in two approaches: a direct or an indirect mechanism.
Bremelanotide does not meaningfully interact with alcohol, unlike flibanserin (for which the interaction with alcohol is a major barrier to its use). [ 13 ] [ 14 ] However, bremelanotide does interact with certain medications that people take by mouth.
She sold Sprout to Valeant in 2015 after the company won FDA approval for the drug Addyi, the first drug designed to enhance female libido. [13] Prior to founding Sprout, Eckert co-founded Slate Pharmaceuticals in 2007. Slate was focused on men's sexual health with an FDA approved long acting testosterone product, Testopel.
Here are links to possibly useful sources of information about Flibanserin. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC
Brand name Addyi. Created with ChemDoodle 7.0.2 and Adobe Illustrator CC 2015. Date: 27 June 2015: Source: Own work: ... Flibanserin; Usage on or.wikipedia.org